Filing Details
- Accession Number:
- 0001140361-13-040495
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-04 17:00:57
- Reporting Period:
- 2013-10-31
- Filing Date:
- 2013-11-04
- Accepted Time:
- 2013-11-04 17:00:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 350907 | Thoratec Corp | THOR | Electromedical & Electrotherapeutic Apparatus (3845) | 942340464 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1307313 | F Gerhard Burbach | 6035 Stoneridge Drive Pleasanton CA 94588 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-10-31 | 55,000 | $23.62 | 211,307 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-10-31 | 11,955 | $41.46 | 199,352 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-10-31 | 23,045 | $42.13 | 176,307 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-10-31 | 20,000 | $43.02 | 156,307 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-10-31 | 55,000 | $0.00 | 55,000 | $23.62 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 252,104 | 2007-01-17 | 2016-01-17 | No | 4 | M | Direct |
Footnotes
- Options were granted pursuant to the Company's equity incentive plan with no payments received for the options.
- Options vest in four equal annual installments commencing one year after the grant date.
- Options exercised and shares of Common Stock sold pursuant to a Sales Plan established by the Reporting Person on September 9, 2013, which Sales Plan is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Securities Exchange Act of 1934, as amended.
- This transaction was executed in multiple trades in prices ranging from $41.00 to $41.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades in prices ranging from $42.00 to $42.54. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades in prices ranging from $43.00 to $43.26. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
